In-vitro studies demonstrated thatinhibition of CD26/DPP4 stimulated breast cancer metastasis, likely via induction of CXCL12/CXCR4 (10), while others reported inhibition of CD26/DPP4 led to the suppression of breast cancer tumor growth (11). The gene discussed is DPP4; the disease is breast carcinoma.